These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 32191395)
1. Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion. Oba A; Ito H; Ono Y; Sato T; Mise Y; Inoue Y; Takahashi Y; Saiura A BJS Open; 2020 Jun; 4(3):438-448. PubMed ID: 32191395 [TBL] [Abstract][Full Text] [Related]
2. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer. Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449 [TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion. Han S; Choi DW; Choi SH; Heo JS; Han IW; You YH Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors after pancreatoduodenectomy with en bloc portal venous resection for pancreatic cancer. Lapshyn H; Bronsert P; Bolm L; Werner M; Hopt UT; Makowiec F; Wittel UA; Keck T; Wellner UF; Bausch D Langenbecks Arch Surg; 2016 Feb; 401(1):63-9. PubMed ID: 26739620 [TBL] [Abstract][Full Text] [Related]
5. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma. Wang F; Gill AJ; Neale M; Puttaswamy V; Gananadha S; Pavlakis N; Clarke S; Hugh TJ; Samra JS Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067 [TBL] [Abstract][Full Text] [Related]
6. Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma. Murakami Y; Satoi S; Motoi F; Sho M; Kawai M; Matsumoto I; Honda G; Br J Surg; 2015 Jun; 102(7):837-46. PubMed ID: 25877050 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma. Jeong J; Choi DW; Choi SH; Heo JS; Jang KT ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800 [TBL] [Abstract][Full Text] [Related]
8. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma. Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588 [TBL] [Abstract][Full Text] [Related]
10. Radiological prediction of portal vein infiltration in patients with pancreatic ductal adenocarcinoma. Lapshyn H; Schulte T; Sondermann S; May K; Petrova E; Honselmann KC; Braun R; Zemskov S; Keck T; Wellner UF; Bausch D; Bolm L Pancreatology; 2021 Jan; 21(1):155-162. PubMed ID: 33309623 [TBL] [Abstract][Full Text] [Related]
11. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion. Wang WL; Ye S; Yan S; Shen Y; Zhang M; Wu J; Zheng SS Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):429-35. PubMed ID: 26256089 [TBL] [Abstract][Full Text] [Related]
13. Comparison of end-to-end anastomosis and interposition graft during pancreatoduodenectomy with portal vein reconstruction for pancreatic ductal adenocarcinoma. Terasaki F; Fukami Y; Maeda A; Takayama Y; Takahashi T; Uji M; Kaneoka Y Langenbecks Arch Surg; 2019 Mar; 404(2):191-201. PubMed ID: 30631907 [TBL] [Abstract][Full Text] [Related]
14. Pancreatoduodenectomy with portal vein resection is feasible and potentially beneficial for elderly patients with pancreatic cancer. Kanda M; Fujii T; Suenaga M; Takami H; Inokawa Y; Yamada S; Kobayashi D; Tanaka C; Sugimoto H; Nomoto S; Fujiwara M; Kodera Y Pancreas; 2014 Aug; 43(6):951-8. PubMed ID: 24717827 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of cryopreserved homologous veins for venous reconstruction in pancreatoduodenectomy. Yamamoto M; Akamatsu N; Aoki T; Sakamoto Y; Tamura S; Hasegawa K; Kokudo N Surgery; 2017 Feb; 161(2):385-393. PubMed ID: 27726914 [TBL] [Abstract][Full Text] [Related]
16. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. Riediger H; Makowiec F; Fischer E; Adam U; Hopt UT J Gastrointest Surg; 2006; 10(8):1106-15. PubMed ID: 16966029 [TBL] [Abstract][Full Text] [Related]
17. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens. Delpero JR; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Autret A; Turrini O; Monges-Ranchin G; Boher JM HPB (Oxford); 2014 Jan; 16(1):20-33. PubMed ID: 23464850 [TBL] [Abstract][Full Text] [Related]
18. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions. Pine JK; Haugk B; Robinson SM; Darne A; Wilson C; Sen G; French JJ; White SA; Manas DM; Charnley RM Pancreatology; 2020 Apr; 20(3):537-544. PubMed ID: 31996296 [TBL] [Abstract][Full Text] [Related]
19. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas. Banz VM; Croagh D; Coldham C; Tanière P; Buckels J; Isaac J; Mayer D; Muiesan P; Bramhall S; Mirza DF Eur J Surg Oncol; 2012 Jan; 38(1):72-9. PubMed ID: 22054617 [TBL] [Abstract][Full Text] [Related]